Hypochlorous Acid for Wounds: What It Is & How It Works

Hypochlorous acid (HOCl) is a naturally occurring molecule your immune system produces to kill bacteria, and when applied topically to wounds, it works in much the same way: destroying pathogens on contact while remaining gentler on human tissue than most conventional antiseptics. What makes HOCl unusual in wound care is that it is not a pharmaceutical invention but a synthetic copy of something your white blood cells already manufacture. That biology-meets-chemistry story explains both why it works and why it has attracted growing clinical interest, particularly for hard-to-treat infections.

Your Body Already Makes It

When your immune system detects an invader, a type of white blood cell called a neutrophil swallows the pathogen whole. Inside a sealed compartment, the neutrophil undergoes what researchers call a “respiratory burst,” a spike in oxygen consumption that generates hydrogen peroxide. An enzyme called myeloperoxidase then converts that hydrogen peroxide and chloride ions into hypochlorous acid, which is the primary killing agent inside the compartment.¹ In other words, HOCl is part of your body’s built-in disinfection toolkit, and it has been for as long as mammals have had immune systems.

This endogenous production is not a minor side reaction. Myeloperoxidase is one of the most abundant enzymes in neutrophils, and the reactive chlorinated species it generates contribute significantly to oxidative stress aimed at pathogens.² Recognizing that the body already relies on HOCl gave researchers a reason to believe that applying it externally could be both effective and well-tolerated, a hypothesis that has held up well in practice.

How It Kills Bacteria

HOCl does not work the way most antibiotics do. Antibiotics typically target one specific process inside a bacterium, such as building a cell wall or copying DNA. HOCl takes a broader approach: it attacks the membranes and energy-producing machinery of bacteria simultaneously. Research on common wound pathogens including E. coli and Pseudomonas aeruginosa showed that lethal doses of HOCl caused their cellular energy to collapse almost immediately, dropping from healthy levels to near zero. Transport of nutrients across the bacterial membrane and the enzyme responsible for making ATP both shut down, meaning the bacterium loses its ability to generate energy through any pathway at all.³

This multi-target attack is part of the reason bacteria have difficulty developing resistance to HOCl. An antibiotic that blocks a single enzyme can be defeated by a single mutation that changes the shape of that enzyme. HOCl damages so many things at once, including membrane proteins, transport channels, and metabolic enzymes, that no single mutation can protect against it. The same broad-spectrum oxidative mechanism that your neutrophils rely on to handle a variety of invaders makes synthetic HOCl effective against gram-positive bacteria, gram-negative bacteria, fungi, and viruses.

Why pH Matters So Much

Chlorine-based antimicrobials exist on a spectrum determined by pH. At very low pH, you get chlorine gas. In alkaline conditions, you get sodium hypochlorite, which is essentially dilute bleach. HOCl dominates in the slightly acidic to mildly acidic range, roughly pH 3.5 to 5. Keeping a solution in this window maximizes the amount of active HOCl while minimizing unwanted byproducts.⁴

This pH sensitivity is both HOCl’s strength and its practical challenge. At the right pH, HOCl is estimated to be roughly 80 to 100 times more effective as a germicide than sodium hypochlorite, largely because the neutral HOCl molecule can pass through bacterial membranes far more easily than the negatively charged hypochlorite ion.⁵ However, if the pH drifts too high during storage or after dilution, the active ingredient quietly converts to hypochlorite and loses much of its punch. This is why modern wound-care formulations emphasize “stabilized” HOCl, solutions engineered to hold their pH over weeks or months. When you pick up a bottle of HOCl wound spray, the manufacturing challenge that went into it was largely about keeping that pH steady.

The Biofilm Problem

One reason chronic wounds stall is biofilm, a slimy matrix that bacteria build around themselves as a protective fortress. Biofilm is not just a cosmetic nuisance on the wound surface. The sticky layer physically blocks many antimicrobials from reaching the bacteria underneath. Positively charged antibiotics like aminoglycosides get trapped by the negatively charged matrix, and even common wound-cleaning agents like hydrogen peroxide lose effectiveness against biofilm-embedded bacteria.

HOCl faces this challenge too, but its neutral molecular charge gives it a penetration advantage. In lab testing, chlorhexidine (a widely used antiseptic) lost the most germ-killing power in the presence of biofilm, while HOCl at higher concentrations retained the best activity of the antiseptics tested.⁶ This is particularly relevant for chronic wounds like diabetic foot ulcers, where biofilm can persist for months and resist repeated courses of antibiotics. Researchers have also explored continuous low-level delivery of HOCl through electrochemical scaffolds, with the idea that a slow, sustained trickle of the molecule can keep dissolving biofilm faster than the bacteria can rebuild it.⁵

Safety and Tissue Tolerance

Any antiseptic faces the same basic tradeoff: the more aggressively it kills bacteria, the more it risks damaging the healthy cells trying to heal the wound. HOCl is not exempt from this. In vitro testing of commercial HOCl and sodium hypochlorite solutions found that increasing antimicrobial strength was generally associated with decreasing cell viability, and both the antimicrobial effect and the cytotoxic effect grew with higher concentrations and longer exposure times.⁷

What tilts the balance in HOCl’s favor is that at the concentrations used in wound-care products (typically in the range of a few hundred parts per million), the molecule is effective enough against pathogens while staying mild enough for tissues. Unlike full-strength bleach or high-concentration hydrogen peroxide, properly formulated HOCl solutions do not sting significantly on application, a practical detail that matters when you need to irrigate a wound repeatedly. Multiple studies and clinical reviews describe HOCl as having both antimicrobial and anti-inflammatory properties in the context of skin wounds, diabetic ulcers, and inflammatory skin conditions.⁸ The anti-inflammatory effect is an added benefit: rather than just clearing bacteria, HOCl appears to help calm the exaggerated inflammatory response that keeps chronic wounds from progressing through normal healing stages.

How It Compares to Other Wound Antiseptics

In practical wound care, HOCl competes with a handful of established antiseptics: povidone-iodine, chlorhexidine, and hydrogen peroxide are the most common. Each has pros and cons, and the picture is not as simple as one being universally best.

Against free-floating bacteria in a test tube, chlorhexidine at standard clinical concentration kills fastest, typically within the first minute. But by the five-minute mark, HOCl at moderate concentrations matches or exceeds the other antiseptics, and at higher concentrations it outperforms them all, especially in the presence of biofilm.⁶ Against povidone-iodine specifically, a clinical trial on infected diabetic foot ulcers found that HOCl was more effective against gram-negative bacteria, while both antiseptics performed equally against gram-positive bacteria.⁹ Since gram-negative bacteria (like Pseudomonas and Klebsiella) are among the most common and troublesome wound pathogens, that advantage is clinically meaningful.

Hydrogen peroxide, meanwhile, has largely fallen out of favor for repeated wound care. While it does have oxidizing antimicrobial activity, it is harsher on healthy tissue, and clinical trials suggest it cannot fully eliminate common wound bacteria the way HOCl can. In one study of diabetic foot ulcers, hydrogen peroxide reduced bacterial counts but failed to completely eradicate any of five tested bacterial species within 30 days, while HOCl eliminated most of them within 15 to 25 days.¹⁰

Evidence in Chronic Wounds

Chronic wounds, especially diabetic foot ulcers, are where HOCl has attracted the most clinical attention. These wounds are notoriously difficult to heal: they tend to be heavily colonized by bacteria (often drug-resistant strains), wrapped in biofilm, and stuck in a prolonged inflammatory state. Standard wound care involves debridement, offloading pressure, and dressings, but infection control often requires additional intervention.

In a controlled study comparing HOCl irrigation to hydrogen peroxide in infected diabetic foot ulcers, wounds in the HOCl group became visibly clean in 70 percent of patients by day 10 and 100 percent by day 15. The hydrogen peroxide group lagged far behind, with only about half showing clean wounds by day 30. Ulcer depth and width also decreased significantly faster in the HOCl group.¹⁰ A separate case series using stabilized HOCl for diabetic foot ulcer irrigation found that it prevented infection in chronic wounds and allowed natural healing to proceed without adverse effects, supporting its integration into routine diabetic foot care.¹¹

It is worth noting that much of the clinical literature on HOCl in wound care is still relatively small in scale, with many studies being case series, small trials, or single-center studies rather than large multicenter randomized controlled trials. The direction of the evidence is consistent and favorable, but the field has not yet reached the level of proof that, say, negative-pressure wound therapy has for chronic wounds. Clinicians tend to view HOCl as a well-supported adjunct to standard wound care rather than a standalone miracle cure.

From World War I Trenches to Modern Formulations

The idea of using chlorine-based solutions on wounds is more than a century old. During World War I, a chemist named Henry Dakin developed a dilute sodium hypochlorite solution (Dakin’s solution) for treating contaminated battlefield injuries. It was labor-intensive to administer and sometimes unpredictable, but it saved lives and limbs at a time when antibiotics did not yet exist.¹² Dakin’s solution remained the standard treatment for contaminated wounds until antibiotics arrived during World War II, at which point antiseptics fell out of fashion for decades.

Interest revived in the 1980s when antibiotic-resistant organisms began appearing in hospitals and chronic wound clinics.¹² But Dakin’s original solution was alkaline sodium hypochlorite, not the pH-optimized hypochlorous acid used today. Modern formulations represent a meaningful evolution: by controlling pH to keep the chlorine in its most active and least irritating form, today’s HOCl products deliver better antimicrobial punch with less tissue damage than Dakin’s solution ever could. The shift from “dilute bleach” to “stabilized hypochlorous acid” sounds subtle, but it changes the clinical profile considerably.

Electrochemical Bandages and Continuous Delivery

One limitation of spraying or irrigating a wound with HOCl is that the molecule is reactive and short-lived. It does its work and breaks down, which means you need to reapply it. Researchers have been working on a more creative approach: bandages that generate HOCl directly on the wound surface using a small electric current.

These “e-bandages” contain electrodes woven into the dressing material. When polarized with a weak current, they electrochemically split saline (salt water) in the wound fluid to produce HOCl continuously. In a mouse study of wounds infected with Pseudomonas aeruginosa, 48 hours of treatment with a polarized e-bandage reduced biofilm bacteria by about 100-fold compared to a standard adhesive dressing alone. The e-bandage group also showed less visible pus than the controls. Interestingly, adding the antibiotic amikacin improved outcomes in the control groups but did not provide additional benefit on top of the e-bandage, suggesting the continuous HOCl was already doing what the antibiotic would have done.¹³ Wound closure was neither helped nor hindered by the bandage, which is consistent with what you would expect from an antimicrobial intervention rather than a tissue-growth promoter. This technology is still experimental, but it points toward a future where wound dressings actively manage infection rather than just covering the wound.

Beyond Human Medicine

HOCl has also gained traction in veterinary wound care, partly because the same antibiotic-resistance challenges that affect human medicine apply to animals. In a clinical trial on dog bite wounds, hypochlorous acid and polyhexanide (another common veterinary antiseptic) performed equally well at reducing bacterial contamination. Neither was clearly superior for decontamination, but HOCl had the practical advantage of requiring a shorter contact time, which matters when you are trying to clean a wound on an uncooperative patient.¹⁴

In cattle, HOCl spray was tested against infectious bovine keratoconjunctivitis (pinkeye) caused by M. bovis. Treated calves had lower pain scores, faster healing of corneal lesions, and cleared the infection more effectively than untreated controls. Tissue testing showed no accumulation of chlorine in muscle, liver, fat, or urine, an important finding for food-producing animals where chemical residues are a regulatory concern.¹⁵ Rabbit wound-healing studies have similarly found that HOCl supports normal dermal healing without adverse effects.¹⁶

Skin Conditions and Off-Label Uses

While wound irrigation is the most studied application, HOCl has found its way into a wider range of dermatological uses. Clinical reviews note its use for pruritus (itching), inflammatory skin disorders, and as a general skin cleanser for conditions like eczema and atopic dermatitis.⁸ Some dermatologists recommend dilute bleach baths for eczema patients colonized with Staphylococcus aureus; HOCl sprays offer a more targeted and pH-controlled way to achieve a similar antimicrobial effect without submerging in a bathtub of diluted bleach.

The consumer skincare market has also embraced HOCl, with sprays and mists marketed for acne, post-procedure care after chemical peels or laser treatments, and general facial hygiene. The evidence for these cosmetic applications is thinner than for wound care, but the logic is at least consistent: if HOCl reduces bacterial load and calms inflammation without major irritation, it could plausibly help with acne or post-procedure redness. Just be aware that the concentrations and formulations in consumer skincare sprays vary widely, and a product labeled “hypochlorous acid” is not necessarily identical to the stabilized wound-care solutions used in clinical studies. Checking the pH and concentration, if listed, gives you a better sense of what you are actually getting.

Practical Tips for Using HOCl on Wounds

If you are considering HOCl for wound care at home or have been prescribed it by a clinician, a few practical details are worth knowing:

• Ready to use: Most commercial HOCl wound solutions come pre-mixed and do not need dilution with water or saline.¹⁷ Diluting them yourself risks shifting the pH out of the effective range.
• Storage matters: HOCl degrades over time, especially when exposed to heat, light, or air. Keep bottles sealed, stored in a cool place, and use them before the expiration date. An expired bottle may contain mostly inactive hypochlorite rather than HOCl.
• Not a substitute for medical care: For deep, infected, or non-healing wounds, HOCl is an adjunct to professional wound management, not a replacement for it. Debridement, appropriate dressings, and sometimes systemic antibiotics are still necessary depending on wound severity.
• Concentration varies by product: Wound-care products and skincare sprays may have very different HOCl concentrations. A product formulated for wound irrigation at several hundred parts per million is not interchangeable with a facial mist at much lower concentrations.

The Antibiotic Resistance Angle

Part of the renewed enthusiasm for HOCl in wound care is driven by the antibiotic resistance crisis. Chronic wounds frequently harbor drug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and clinicians are looking for ways to reduce bacterial load without adding to the selective pressure that breeds resistance. HOCl’s broad oxidative mechanism, which damages multiple bacterial targets simultaneously rather than one specific enzyme, makes it theoretically difficult for bacteria to develop resistance against. This stands in sharp contrast to conventional antibiotics, where resistance often evolves through a single genetic change.

Research evaluating HOCl and hydrogen peroxide against bacterial species commonly found in wound infections, including drug-resistant isolates, has reinforced this picture.¹⁸ The clinical implication is straightforward: using HOCl for local wound decontamination could reduce the need for topical or systemic antibiotics, reserving those drugs for situations where they are truly necessary. A veterinary trial on dog bite wounds was designed with exactly this rationale, aiming to see whether antiseptic lavage with HOCl could prevent the routine use of prophylactic antibiotics.¹⁴ As antibiotic stewardship becomes an increasingly urgent priority in both human and veterinary medicine, antiseptics like HOCl that can shoulder some of the antimicrobial burden without feeding resistance are likely to take on a bigger role.